Name: | NABRIVA THERAPEUTICS US, INC. |
Jurisdiction: | New York |
Legal type: | FOREIGN BUSINESS CORPORATION |
Status: | Inactive |
Date of registration: | 20 Jun 2018 (7 years ago) |
Date of dissolution: | 11 Mar 2025 |
Entity Number: | 5362705 |
ZIP code: | 94583 |
County: | New York |
Place of Formation: | Delaware |
Principal Address: | 414 Commerce Drive, Suite 120, Fort Washington, PA, United States, 19034 |
Address: | 231 market place, suite 373, SAN RAMON, CA, United States, 94583 |
Name | Role | Address |
---|---|---|
the corporation | DOS Process Agent | 231 market place, suite 373, SAN RAMON, CA, United States, 94583 |
Name | Role |
---|---|
Registered Agent Revoked | Agent |
Name | Role | Address |
---|---|---|
TED SCHROEDER | Chief Executive Officer | 414 COMMERCE DRIVE, SUITE 120, FORT WASHINGTON, PA, United States, 19034 |
Start date | End date | Type | Value |
---|---|---|---|
2025-03-14 | 2025-03-14 | Address | 1000 CONTINENTAL DRIVE, SUITE 600, KING OF PRUSSIA, PA, 19406, USA (Type of address: Chief Executive Officer) |
2025-03-14 | 2025-03-14 | Address | 414 COMMERCE DRIVE,, SUITE 120, FORT WASHINGTON, PA, 19034, USA (Type of address: Chief Executive Officer) |
2025-03-14 | 2025-03-14 | Address | 414 COMMERCE DRIVE, SUITE 120, FORT WASHINGTON, PA, 19034, USA (Type of address: Chief Executive Officer) |
2024-07-11 | 2024-07-11 | Address | 414 COMMERCE DRIVE, SUITE 120, FORT WASHINGTON, PA, 19034, USA (Type of address: Chief Executive Officer) |
2024-07-11 | 2024-07-11 | Address | 414 COMMERCE DRIVE,, SUITE 120, FORT WASHINGTON, PA, 19034, USA (Type of address: Chief Executive Officer) |
Filing Number | Date Filed | Type | Effective Date |
---|---|---|---|
250314001190 | 2025-03-11 | SURRENDER OF AUTHORITY | 2025-03-11 |
240711001499 | 2024-07-11 | BIENNIAL STATEMENT | 2024-07-11 |
220602002235 | 2022-06-02 | BIENNIAL STATEMENT | 2022-06-01 |
200603061364 | 2020-06-03 | BIENNIAL STATEMENT | 2020-06-01 |
SR-83388 | 2019-01-28 | CERTIFICATE OF CHANGE (BY AGENT) | 2019-01-28 |
Date of last update: 23 Mar 2025
Sources: New York Secretary of State